SCHEMBL4029113

SCHEMBL4029113

CCCn1c(C2CCN(C(=O)OCc3ccccc3)CC2)nc(-c2cccc(C(F)(F)F)c2)c1-c1ccncc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 1/20 0.43
GRIN2B Q13224 3/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C9 P11712 2/20 0.42
MAPK11 Q15759 4/20 0.41
MAPK14 Q16539 4/20 0.41
F2R P25116 1/20 0.41
CETP P11597 1/20 0.41
MAPK13 O15264 3/20 0.41
MAPK9 P45984 3/20 0.41
MAPK12 P53778 3/20 0.41
RAF1 P04049 1/20 0.41
TRPC3 Q13507 3/20 0.41
TRPC7 Q9HCX4 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4027551 0.90 MAPK14 (0.41) TRPV4MAPK11MAPK14MAPK13MAPK9
SCHEMBL8605119 0.87 TMEM97 (0.47) TRPV4MAPK11MAPK14SMN1; SMN2UBE2M
SCHEMBL4025102 0.84 MAPK14 (0.52) TRPV4GRIN2BMAPK11MAPK14F2R
SCHEMBL8011517 0.84 MAPK14 (0.52) TRPV4GRIN2BMAPK11MAPK14F2R
SCHEMBL4027239 0.81 MAPK14 (0.43) TRPV4GRIN2BCYP2D6CYP2C9MAPK11
SCHEMBL6172327 0.80 MAPK14 (0.50) TRPV4GRIN2BMAPK11MAPK14F2R
SCHEMBL4027753 0.80 MAPK14 (0.53) MAPK11MAPK14MAPK13MAPK9MAPK12
SCHEMBL7463352 0.80 GRIN2B (0.46) TRPV4GRIN2BCYP2D6CYP2C9MAPK11
SCHEMBL5760979 0.79 MAPK14 (0.46) TRPV4GRIN2BMAPK11MAPK14F2R
SCHEMBL6172304 0.79 MAPK14 (0.49) TRPV4GRIN2BMAPK11MAPK14F2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0854870-B1 SUBSTITUTED IMIDAZOLES HAVING ANTI-CANCER AND CYTOKINE INHIBITORY ACTIVITY MERCK & CO INC (US) 2009-06-10 EP claimed
EP-0854870-B1 SUBSTITUTED IMIDAZOLES HAVING ANTI-CANCER AND CYTOKINE INHIBITORY ACTIVITY MERCK & CO INC (US) 2009-06-10 EP disclosed
US-6083949-A FOR TREATING CANCER IN WHICH RAF KINASE IS IMPLICATED, AS WELL AS COMPOUNDS WHICH INHIBIT, SUPPRESS OR ANTAGONIZE THE PRODUCTION OR ACTIVITY OF CYTOKINES SUCH AS INTERLEUKINS AND TUMOR NECROSIS FACTOR MERCK & CO., INC. (US) 2000-07-04 US disclosed